Nova Eye Medical (EYE) Discussion, page-1966

First 1966 Last

Share
Profile

Follow
doctormining

120 Posts.

18

11/01/24

17:42

Post #: 71836988
Share

Originally posted by TheAnalyst007: ↑

Definitely agree, I wouldn't say we are a blue-chip stock yet lol, but I definitely wouldn't say this is remotely close to high risk either, especially after the recent news. However, it certainly does feel like the market is pricing this stock as if it is a dud!

We have already seen how iTrack Advance performs in even the worst market conditions. When the LCD was looking almost certain to be implemented, other companies experienced significant reductions in order volumes, whilst EYE outperformed significantly, recording 65% growth over the period. If they could perform that strongly then, it is hard to see how they won't see spectacular long-term growth now that reimbursement fears are gone. Pretty easy to see that revenue will continue to grow very high very fast.

Profitability is still speculative I guess, but the trend is pretty clear. In H1FY23 they recorded a loss of -$6m. In H2FY23 that improved significantly to only -$2m. Not sure what it will be in H1FY24, but I am keen to see as it will most likely indicate whether or not we can expect to breakeven this financial year.

2RT is clearly very speculative, but it isn't risky (imo). Clearly, at only a 2x revenue multiple the market isn't even pricing in the high growth associated with iTrack Advance, and especially not the potential of 2RT and other R&D. Even if 2RT goes absolutely no where, at such a low valuation, iTrack Advance alone would be sufficient to carry the share price well over a dollar. We basically have a free option to benefit from any upside associated with 2RT, with none of the downside risk.

Expand

thanks for the posts, buy

EYE Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

End of FY is a time to juggle wins, losses and capital gains taxes

SS1

Sun Silver submits US$60M Silver Paste Funding Application to US DoE

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Eurozone-based companies find new ways to secure a regional lithium supply

Time for retail therapy buying in the shopping Scentre for hot stocks

There are more pages in this discussion • 1,157 more messages in this thread...

First 1966 Last

Add EYE (ASX) to my watchlist

(20min delay)
Last 21.5¢		Change 0.000(0.00%)		Mkt cap ! $50.34M

Open	High	Low	Value	Volume
22.0¢	22.0¢	21.5¢	$51.71K	240.4K

Buyers (Bids)

No.	Vol.	Price($)
1	95509	21.5¢

Sellers (Offers)

Price($)	Vol.	No.
22.0¢	45158	4

View Market Depth

No.	Vol.	Price($)
1	95509	0.215
7	167799	0.210
3	79540	0.205
18	285320	0.200
1	3000	0.195

Price($)	Vol.	No.
0.220	45158	4
0.225	21173	2
0.230	10031	3
0.235	110000	2
0.245	11000	1

Last trade - 12.43pm 26/06/2024 (20 minute delay)

EYE (ASX) Chart

Nova Eye Medical (EYE) Discussion, page-1966

End of FY is a time to juggle wins, losses and capital gains taxes

Sun Silver submits US$60M Silver Paste Funding Application to US DoE

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Eurozone-based companies find new ways to secure a regional lithium supply

Time for retail therapy buying in the shopping Scentre for hot stocks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Nova Eye Medical (EYE) Discussion, page-1966

Top Stories

End of FY is a time to juggle wins, losses and capital gains taxes

Sun Silver submits US$60M Silver Paste Funding Application to US DoE

ASX200 dives as inflation clocks in at 4% – higher than 3.8% consensus

Eurozone-based companies find new ways to secure a regional lithium supply

Time for retail therapy buying in the shopping Scentre for hot stocks

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News